PMID- 21868718
OWN - NLM
STAT- MEDLINE
DCOM- 20120727
LR  - 20120302
IS  - 1941-2444 (Electronic)
IS  - 0148-6071 (Linking)
VI  - 36
IP  - 2
DP  - 2012 Mar
TI  - Percutaneous endoscopic gastrostomy complication rates and compliance with the 
      American Society for Gastrointestinal Endoscopy guidelines for the management of 
      antithrombotic therapy.
PG  - 226-30
LID - 10.1177/0148607111413897 [doi]
AB  - BACKGROUND: The American Society for Gastrointestinal Endoscopy (ASGE) has 
      published recommendations in regards to anticoagulant (AC) and antiplatelet (AP) 
      therapy management during endoscopic procedures. So far, no study has assessed 
      either ASGE recommendation compliance during percutaneous endoscopic gastrostomy 
      (PEG) placement or procedure-associated complication rates as related to the 
      observance of these recommendations. The aims of this study were to compare the 
      incidence and type of complications during PEG placement in patients receiving or 
      not receiving AC and/or AP therapy and to determine the compliance with ASGE's AC 
      and AP management guidelines. METHODS: Medical files of patients who underwent 
      PEG placement from January 2004 to December 2008 were reviewed. Clinical and 
      procedure-related data were recorded. Patients were separated into 1 of 2 groups: 
      patients under AP and/or AC therapy prior to PEG placement (n = 51) and a control 
      group of patients (n = 40) not receiving any AP and/or AC treatment at least 6 
      months prior to the procedure. RESULTS: A total of 91 patients (51 cases) were 
      included. Groups were comparable in demographics and clinical characteristics. No 
      differences in the frequency and type of complications were found between groups. 
      ASGE's recommendations were not followed in any of these patients. CONCLUSIONS: 
      Overall PEG placement complication rate was 13.7%. AP therapy may be safely 
      discontinued closer to the time of endoscopic procedure than the time currently 
      recommended by the ASGE guidelines.
FAU - Lozoya-Gonzalez, Diego
AU  - Lozoya-Gonzalez D
AD  - Advanced Endoscopy Unit, ABC Medical Center, Mexico DF, Mexico.
FAU - Pelaez-Luna, Mario
AU  - Pelaez-Luna M
FAU - Farca-Belsaguy, Alberto
AU  - Farca-Belsaguy A
FAU - Salceda-Otero, Juan C
AU  - Salceda-Otero JC
FAU - Vazquez-Ballesteros, Edgar
AU  - Vazquez-Ballesteros E
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20110825
PL  - United States
TA  - JPEN J Parenter Enteral Nutr
JT  - JPEN. Journal of parenteral and enteral nutrition
JID - 7804134
RN  - 0 (Anticoagulants)
RN  - 0 (Platelet Aggregation Inhibitors)
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Anticoagulants/*therapeutic use
MH  - Disease Management
MH  - Enteral Nutrition/methods
MH  - Female
MH  - Gastroscopy/*adverse effects/methods
MH  - Gastrostomy/*adverse effects/methods
MH  - *Guideline Adherence
MH  - Humans
MH  - Incidence
MH  - Intubation, Gastrointestinal/*adverse effects
MH  - Male
MH  - Middle Aged
MH  - Platelet Aggregation Inhibitors/*therapeutic use
MH  - Postoperative Complications/*epidemiology
MH  - Practice Guidelines as Topic
MH  - Societies, Medical
MH  - Thrombosis/prevention & control
EDAT- 2011/08/27 06:00
MHDA- 2012/07/28 06:00
CRDT- 2011/08/27 06:00
PHST- 2011/08/27 06:00 [entrez]
PHST- 2011/08/27 06:00 [pubmed]
PHST- 2012/07/28 06:00 [medline]
AID - 0148607111413897 [pii]
AID - 10.1177/0148607111413897 [doi]
PST - ppublish
SO  - JPEN J Parenter Enteral Nutr. 2012 Mar;36(2):226-30. doi: 
      10.1177/0148607111413897. Epub 2011 Aug 25.